| Literature DB >> 26146997 |
Brittany E Goldberg1, Emmanuel F Mongodin2, Cheron E Jones3, Michelle Chung4, Claire M Fraser5, Anupama Tate4, Steven L Zeichner6.
Abstract
The oral microbial community (microbiota) plays a critical role in human health and disease. Alterations in the oral microbiota may be associated with disorders such as gingivitis, periodontitis, childhood caries, alveolar osteitis, oral candidiasis and endodontic infections. In the immunosuppressed population, the spectrum of potential oral disease is even broader, encompassing candidiasis, necrotizing gingivitis, parotid gland enlargement, Kaposi's sarcoma, oral warts and other diseases. Here, we used 454 pyrosequencing of bacterial 16S rRNA genes to examine the oral microbiome of saliva, mucosal and tooth samples from HIV-positive and negative children. Patient demographics and clinical characteristics were collected from a cross-section of patients undergoing routine dental care. Multiple specimens from different sampling sites in the mouth were collected for each patient. The goal of the study was to observe the potential diversity of the oral microbiota among individual patients, sample locations, HIV status and various dental characteristics. We found that there were significant differences in the microbiome among the enrolled patients, and between sampling locations. The analysis was complicated by uneven enrollment in the patient cohorts, with only five HIV-negative patients enrolled in the study and by the rapid improvement in the health of HIV-infected children between the time the study was conceived and completed. The generally good oral health of the HIV-negative patients limited the number of dental plaque samples that could be collected. We did not identify significant differences between well-controlled HIV-positive patients and HIV-negative controls, suggesting that well-controlled HIV-positive patients essentially harbor similar oral flora compared to patients without HIV. Nor were significant differences in the oral microbiota identified between different teeth or with different dental characteristics. Additional studies are needed to better characterize the oral microbiome in children and those with poorly-controlled HIV infections.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26146997 PMCID: PMC4492946 DOI: 10.1371/journal.pone.0131615
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Patient Demographics .
| Patient ID | Age (yrs) | Gender | Race | HIV Status | Past Medical History | Plaque Score | Medications | Oral Pathology | CD4 Percent (%) | CD4 Absolute Count (cells/mm3) | Viral Load (copies/mL) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 13 | Male | African American | HIV/B1 | None | Poor | LPV/r, TDF, ZDV | None | 40 | 770 | Undetectable |
| 2 | 13 | Female | African American | HIV/C3 | None | Fair | d4T, NFV, DDI, | None | 60 | 1200 | <100 |
| 3 | 12 | Male | African American | HIV | None | Poor | LPV/r, 3TC, ZDV | LGE | 30 | 530 | Undetectable |
| 4 | 10 | Female | African American | HIV/B3 | None | Poor | ABC/3TC, EFV, TMP/SMX | None | 30 | 370 | <100 |
| 6 | 15 | Male | African American | HIV/B3 | None | Fair | LPV/r, TDF, d4T | None | 30 | 350 | <100 |
| 7 | 15 | Female | African American | HIV/B2 | None | Fair | d4T, ABC, LPV/r, | None | 20 | 620 | <150 |
| 8 | 13 | Male | African American | HIV | Asthma | Fair | Unknown | Unknown | Unknown | Unknown | Unknown |
| 9 | 14 | Female | Native American | HIV/N1 | None | Poor | NVP, ABC, d4T | None | 36 | 1930 | Undetectable |
| 11 | 17 | Female | African American | HIV/C3 | None | Fair | EFV/FTC/TDF, | None | 40 | 760 | Undetectable |
| 12 | 5 | Female | African American | HIV | None | Fair | ZDV, 3TC, NVP | None | 40 | 1970 | Undetectable |
| 13 | 12 | Female | African American | HIV/B2 | None | Fair | None | 20 | 380 | <1500 | |
| 10 | 10 | Male | African American | Neg. | None | Fair | None | None | N/A | N/A | N/A |
| 14 | 12 | Male | White | Neg. | None | Fair | None | None | N/A | N/A | N/A |
| 15 | 16 | Female | White | Neg. | None | Good | None | None | N/A | N/A | N/A |
| 16 | 8 | Female | African American | Neg. | None | Fair | None | None | N/A | N/A | N/A |
| 17 | 4 | Female | African American | Neg. | None | Good | None | None | N/A | N/A | N/A |
a Table 1 contains demographic information for all patients with sequenced samples. No additional treatment information was available for patient 8. Ages, viral loads and CD4 values were rounded to two significant digits to maintain patient privacy.
3TC–lamivudine, ABC–abacavir, AZT—d4T = stavudine, ddI–didanosine, EFV–efavirenz, FTC–emtricitabine, LPV/r–lopinavir/ritonavir, NFV–nelfinavir, NVP–nevirapine, TDF–tenofovir, ZDV–zidovudine, SMZ-TMP–sulfamethoxazole and trimethoprim, LGE–linear gingival erythema.
Dental Characteristics .
| HIV-Positive Patients n = 8 | HIV-Negative Patients n = 5 | |||
|---|---|---|---|---|
| Yes | No | Yes | No | |
|
| 0 | 8 | 2 | 3 |
|
| 2 | 6 | 4 | 1 |
|
| 8 | 0 | 5 | 0 |
|
| 4 | 4 | 5 | 0 |
|
| 1 | 7 | 1 | 4 |
|
| 5 | 3 | 4 | 1 |
|
| 6 | 2 | 4 | 1 |
|
| 6 | 2 | 1 | 4 |
a Patient dental characteristics were collected for each enrolled patient. No data was available for three HIV-positive patients.
The indicator “No” for the entry “0 to 5 Cariogenic Exposures” indicates that the patient had more than 5 cariogenic exposures.
Daily Dental Care.
| HIV-Positive Patients n = 8 | HIV-Negative Patients n = 5 | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
|
| 0 | 4 | 4 | 0 | 3 | 2 |
|
|
|
|
|
|
| |
|
| 6 | 1 | 1 | 2 | 2 | 1 |
Diversity and Richness Estimators .
| N | Observed Number of OTUs | Chao1 | Shannon | Simpson | |
|---|---|---|---|---|---|
| Tooth9 | 11 | 848 | 519.39 (91.54) | 6.13 (0.52) | 0.96 (0.02) |
| Tooth12 | 8 | 847 | 552.70(65.77) | 6.25 (0.48) | 0.96 (0.01) |
| Tooth19 | 11 | 838 | 491.5(121.45) | 5.95 (0.74) | 0.95 (0.03) |
| Tooth25 | 11 | 832 | 476.66(87.06) | 5.83 (0.63) | 0.94 (0.04) |
| Tooth28 | 8 | 792 | 484.05(120.26) | 6.00 (0.75) | 0.95 (0.03) |
| Tooth30 | 11 | 842 | 538.68(63.56) | 5.84 (0.67) | 0.94 (0.04) |
| Tooth3 | 9 | 839 | 538.68(63.56) | 6.31 (0.13) | 0.97 (0.01) |
| Buccal | 16 | 846 | 543.88(102.42) | 5.75 (0.59) | 0.94 (0.03) |
| Dorsal Tongue | 15 | 850 | 560.24(107.22) | 6.09 (0.72) | 0.95 (0.02) |
| Ventral Tongue | 15 | 848 | 523.08(112.49) | 5.66 (1.03) | 0.92 (0.07) |
| Saliva | 14 | 847 | 547.28(132.53) | 6.06 (0.76) | 0.95 (0.03) |
| All HIV negative | 25 | 851 | 495.00(100.34) | 5.91 (0.60) | 0.95 (0.04) |
| All HIV positive | 115 | 849 | 534.9 (94.56) | 5.95 (0.74) | 0.95 (0.03) |
a Mean values of Chao1, Shannon and Simpson diversity indexes are shown for all samples with at least one OTU in greater than 25% of all samples and with an n of greater than 4. Standard deviation is shown in parentheses. Total number of samples and OTUs for each site is displayed.
Fig 1Shannon Diversity Scores.
Boxplots were generated from Shannon diversity scores with quartiles represented in whisker plots and the mean identified by the central point. The Shannon score, which is a measure of species diversity within a sample, is compared between sample locations in Panel A. All Shannon scores for each location, patient or HIV-status are contained in the individual boxplots. Panel B demonstrates that minimal differences were observed between the HIV positive and HIV negative patients. The range of Shannon scores between patients is shown in Panel C. Most patients had scores greater than 5.6. The sole exception was patient 12, who was the only patient under age five. All tooth samples from patient 12 were from primary teeth, and her average shannon score was decreased relative to the other patients with a value of 5.0. All tooth samples are supragingival.
Fig 2Relative Abundance Data at the Phylum level.
All samples with OTUs identified to the phylum level were summarized as bar charts of relative abundance. Relative abundance varied by patient (Panel A) and sample site (Panel B). Panels A and B contain all samples available for each individual patient and sampling sites. The OTU count for each phyla from HIV positive and negative samples were summed in Panel C, demonstrating increased abundance of Firmicutes in HIV positive patients. All tooth samples are supragingival.
Patient Sequencing Data .
| Patient Identifier | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
|
|
|
|
|
|
|
|
|
| |||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
|
|
|
|
|
|
|
|
| ||||||||
|
|
| |||||||||||||||
|
|
| |||||||||||||||
|
|
|
| ||||||||||||||
|
|
|
|
|
| ||||||||||||
|
|
|
|
| |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
a Sample was not uniform for each enrolled patient. Four samples did not provide sufficient DNA amplicons for sequencing. Permanent teeth include Tooth 12 (first premolar), 19 (first molar), 3 (first molar), 30 (first molar), 9(central incisor), 25 (central incisor) and 28 (first premolar). Primary teeth include Tooth P (central incisor), E (central incisor), T (second molar), A (second molar) and I (first molar). Anterior teeth include Tooth 9, 25, P and E. Posterior teeth include 3, 12, 19, 28, 30, A, T and I.
Shannon Diversity Scores .
| P-value (95% CI) | |
|---|---|
| All Patients |
|
| All HIV Patients |
|
| All Samples |
|
| All Teeth | 0.08 |
| All Permanent Teeth | 0.50 |
| All Primary Teeth | 0.34 |
| Primary vs. Permanent Teeth | 0.16 (-0.21,1.06) |
| Anterior vs. Posterior Teeth | 0.37 (-0.49, 0.19) |
| HIV-Positive vs. HIV-Negative Patients | 0.99 (-.028, 0.29) |
| CD4 Count less than 500 | 0.06 (-0.59, 0.01) |
| Plaque Score | 0.40 |
| Flossing Frequency | 0.92 |
| Mouthwash Use | 0.13 (-0.06,0.48) |
| Probiotic Use | 0.13 (-0.50, 0.06) |
a All Shannon diversity scores for each subject group was compared using two-tailed t-tests and ANOVA statistics.
Fig 3Most abundant OTUs.
Relative OTU abundance was summed for primary versus permanent teeth and plaque score. Multiple OTUs may be generated for the same genera, due to the clustering method employed by QIIME. Unique genera consist of OTUs with identical genera assignments, which were summed for each patient group to provide a total abundance for each unique genus. The abundance data was normalized and ranked to identify the ten most abundant genera for each group. Genera identified in only primary or permanent teeth were present in both patient groups, but at lower relative abundance.
Fig 4Principle Coordinate Plots.
Principle coordinate plots were generated from OTU abundance data using the Vegan package in R. Panel A demonstrates coordiates from samples labeled by the HIV status. Panel B contains coordinates from samples labeled by the sample location. Panels C and D depict coordinates from samples labeled by dentition status and patient ID respectively.
Fig 5NMDS Coordinate Plots.
NMDS plots were generated using OTU abundance data using the Vegan package in R. Panel A and B contain coordinates labeled by HIV status and sample location respectively, while Panel C and D contain coordinates labeled by dentition status and patient ID.